Beacon Pointe Advisors, LLC Merck & Co., Inc. Transaction History

Beacon Pointe Advisors, LLC

$8.89 Billion
Q1 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 278,042 shares of MRK stock, worth $34.4 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

278,042

Previous 289,729 4.03%

Holding current value

$34.4 Million

Previous $31.6 Million 16.15%

% of portfolio

0.41%

Previous 0.38%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $1.32 Million - $1.54 Million	-11,687 Reduced 4.03%	278,042 $36.7 Million
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $1.01 Million - $1.1 Million	10,061 Added 3.6%	289,729 $31.6 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $7.77 Million - $8.63 Million	75,484 Added 36.97%	279,668 $28.8 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $4.83 Million - $5.26 Million	-44,455 Reduced 17.88%	204,184 $23.6 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $6.62 Million - $7.39 Million	64,304 Added 34.88%	248,639 $26.5 Million

Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $2.04 Million - $2.61 Million	23,279 Added 14.45%	184,335 $20.4 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $1.76 Million - $1.97 Million	20,796 Added 14.83%	161,056 $13.9 Million
Q2 2022 Aug 11, 2022	SELL	$83.49 - $94.64 $6.19 Million - $7.02 Million	-74,165 Reduced 34.59%	140,260 $12.8 Million
Q1 2022 May 17, 2022	BUY	$73.51 - $82.4 $8.11 Million - $9.09 Million	110,346 Added 106.02%	214,425 $17.6 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $950,482 - $1.19 Million	-13,150 Reduced 11.22%	104,079 $7.98 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $3.11 Million - $3.42 Million	43,438 Added 58.87%	117,229 $8.81 Million
Q2 2021 Aug 17, 2021	BUY	$70.31 - $77.77 $2.91 Million - $3.22 Million	41,440 Added 128.09%	73,791 $5.74 Million
Q1 2021 May 18, 2021	SELL	$68.86 - $81.11 $530,428 - $624,790	-7,703 Reduced 19.23%	32,351 $2.49 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $843,871 - $936,524	11,758 Added 41.55%	40,054 $3.27 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $365,460 - $414,252	-4,994 Reduced 15.0%	28,296 $2.35 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $566,176 - $644,245	8,040 Added 31.84%	33,290 $2.57 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $811,324 - $1.12 Million	12,805 Added 102.89%	25,250 $1.94 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $334,137 - $377,034	4,307 Added 52.92%	12,445 $1.13 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $163,724 - $178,465	-2,152 Reduced 20.91%	8,138 $687,000
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $24,024 - $28,066	-344 Reduced 3.23%	10,290 $865,000
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $17,047 - $19,443	-245 Reduced 2.25%	10,634 $883,000
Q4 2018 Feb 01, 2019	BUY	$65.24 - $75.71 $709,745 - $823,649	10,879 New	10,879 $830,000

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Merck & Co., Inc. Transaction History